Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
EirGenix's Second Breast Cancer Biosimilar EG1206A Successfully Reaches Phase 1 Clinical Trial Objectives 2023-05-08 10:00
Positive Phase III Clinical Results for EirGenix's Proposed Trastuzumab Biosimilar 2021-03-24 23:27
Eirgenix Receives Approval from Japan's PMDA 2020-02-14 15:14
1